http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8124409-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5647aa2a317713b168b101dfc6c9fb0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dac79235889f76d3f73a2e01ad7b462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ad95554364727569f6a650085c3eb99
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10151
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2008-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e27c76c51e2b58877cfe72681e203a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58457f828eb51af13641b41059079aec
publicationDate 2012-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8124409-B2
titleOfInvention Utilizing liver cell line QSG-7701 to be infected with hepatitis B virus
abstract The use of the liver cell line QSG-7701 for HBV infection includes the following steps: directly infecting QSG-7701 cells with purified HBV particles and facilitating the infection by DMSO and/or PEG treatment. The easily available QSG-7701 liver cell line may not require pre-differentiation induction and is naturally susceptible for HBV infection. This cell line provides near normal physiological conditions for HBV infection, especially the infection conditions that are characterized with Chinese origin. This cell line is suitable for investigating the life cycle of HBV. Therefore, this cell line is useful for the investigation of viral infection processes and for the development of drugs that specifically target these processes.
priorityDate 2007-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03011209-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322164
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24177
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID108815027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496482
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100144460
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID174
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11576
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724385
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409974
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507055

Total number of triples: 37.